The proposal attempts to integrate the roles of circulating hormones and that of locally generated mediators including prostaglandins, lipoxgenase products and platelet activating factor in the function of the kidney. The questions to be examined include: 1. What is the exact mechanism by which some hormones stimulate arachidonic acid release? 2. How does this phenomenon relate to the effect of these agents on cell function? 3. Are some of the effects mediated by calcium-phospholipid-dependent protein kinase and, if so, which are the cellular substrates? 4. What is the role of lipoxygenase products on glomerular function and how is their synthesis controlled? 5. Do glomeruli and glomerular cells produce platelet activating factor, and if so is this synthesis altered in renal disease? The tissues to be studied will include: isolated glomeruli, culture of glomerular cells, toad urinary bladder, and isolated collecting tubules. The mechanism of action of vasoactive hormones, e.g. angiotensin II and vasopressin, will be examined in these tissues. Physiological parameters will include contraction of cells and transport of water and solutes. In parallel biochemical events will be determined: phospholipid turnover, arachidonic acid release, synthesis of prostaglandins and lipoxygenase products, synthesis of platelet activating factor (a lipid mediator), cAMP generation, various protein kinases and their endogenous substrates, etc. Identification of the role and mechanism of action of diverse, but interconnected lipid modulators with circulating hormones in vitro should improve our understanding of their in vivo contribution to the physiology and pathophysiology of the kidney. This knowledge will then permit the design of specific therapeutic avenues to glomerular diseases and disorders of the urinary concentrating mechanism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK022036-09
Application #
3227188
Study Section
General Medicine B Study Section (GMB)
Project Start
1978-09-30
Project End
1989-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
9
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Satriano, J A; Banas, B; Luckow, B et al. (1997) Regulation of RANTES and ICAM-1 expression in murine mesangial cells. J Am Soc Nephrol 8:596-603
Neugarten, J; Feith, G W; Assmann, K J et al. (1995) Role of macrophages and colony-stimulating factor-1 in murine antiglomerular basement membrane glomerulonephritis. J Am Soc Nephrol 5:1903-9
Schlondorff, D (1995) The role of chemokines in the initiation and progression of renal disease. Kidney Int Suppl 49:S44-7
Schlondorff, D (1994) Cellular mechanism of glomerular injury: metabolic factors in progressive renal injury. Kidney Int Suppl 45:S54-5
Satriano, J; Schlondorff, D (1994) Activation and attenuation of transcription factor NF-kB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3':5'-cyclic monophosphate. Evidence for involvement of reactive oxygen species. J Clin Invest 94:1629-36
Satriano, J A; Shuldiner, M; Hora, K et al. (1993) Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced J Clin Invest 92:1564-71
Schlondorff, D (1993) Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 22:72-82
Satriano, J A; Hora, K; Shan, Z et al. (1993) Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-gamma, tumor necrosis factor-alpha, IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 150:1971-8
Hora, K; Satriano, J A; Santiago, A et al. (1992) Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony-stimulating factor 1. Proc Natl Acad Sci U S A 89:1745-9
Singhal, P C; Gupta, S; Shen, Z et al. (1991) Effects of PGE2 and a thromboxane A2 analogue on uptake of IgG complexes and LDL by mesangial cells. Am J Physiol 261:F537-44

Showing the most recent 10 out of 13 publications